<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-KSRWKN8M</identifier><date>2012</date><creator>Grošelj-Grenc, Mojca</creator><creator>Kalan, Gorazd</creator><creator>Pavčnik Arnol, Maja</creator><creator>Podnar, Tomaž</creator><creator>Vidmar, Ivan</creator><relation>documents/doc/K/URN_NBN_SI_doc-KSRWKN8M_001.htm</relation><relation>documents/doc/K/URN_NBN_SI_doc-KSRWKN8M_001.pdf</relation><relation>documents/doc/K/URN_NBN_SI_doc-KSRWKN8M_001.txt</relation><format format_type="issue">2</format><format format_type="volume">81</format><format format_type="type">article</format><format format_type="extent">str. 91-97</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">29483737</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-KSRWKN8M</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">Alprostadil</subject><subject language_type_id="slv">Cianoza</subject><subject language_type_id="eng">Cyanosis</subject><subject language_type_id="eng">Diagnosis</subject><subject language_type_id="eng">Drug Therapy</subject><subject language_type_id="eng">Ductus Arteriosus, Patent</subject><subject language_type_id="slv">Duktus arteriozus perzistentni</subject><subject language_type_id="eng">Heart Catheterization</subject><subject language_type_id="eng">Heart Defects, Congenital</subject><subject language_type_id="eng">Infant, Newborn</subject><subject language_type_id="slv">Novorojenček</subject><subject language_type_id="eng">Practice Guidelines</subject><subject language_type_id="slv">Praktična navodila</subject><subject language_type_id="slv">Srce, kateterizacija</subject><subject language_type_id="slv">Srce, napake prirojene</subject><title>Management of newborns with duct-dependent congenital heart disease with prostaglandin E1 - slovenian guidelines</title><title>Obravnava novorojenčkov s prirojeno srčno napako, ki potrebujejo zdravljenje s prostaglandinom E1 - slovenske smernice</title></Record>